MAPK1 and chronic obstructive pulmonary disease: The proinflammatory cytokines interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) have been shown to activate p38 signaling and promote inflammation in COPD patients [17].